Cinven’s Bioclinica merges with ERT, portfolio company of Nordic, Astorg and Novo Holdings

The combination will create a leading independent provider of data and technology for use in clinical trials globally, involved in approximately 4,000 clinical trials each year.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this